1.
Gil Morgan, MD
@weoncologists
Study leading to a tissue agnostic FDA approval in 2022 #RET Tumour-agnostic efficacy and safety of selpercatinib… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
2.
Gil Morgan
@weoncologists
Tomorrow October 27
THE WAIT IS OVER
The @OncoAlert Network is beyond proud to be partners with our good frien… twitter.com/i/web/status/1…
THE WAIT IS OVER
The @OncoAlert Network is beyond proud to be partners with our good frien… twitter.com/i/web/status/1…
Retweet of status by @OncoAlert
3.
4.
5.
6.
7.
Gil Morgan
@weoncologists
JUST OUT
@US_FDA approves Pembro in the tx of patients with high-risk early-stage triple-negative #breastcancer… twitter.com/i/web/status/1…
@US_FDA approves Pembro in the tx of patients with high-risk early-stage triple-negative #breastcancer… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
Optimising the Immune System to Fight #Cancer
Out on @NatureComms
Engineering cells to better navigate through… twitter.com/i/web/status/1…
Out on @NatureComms
Engineering cells to better navigate through… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
Gil Morgan
@weoncologists
An honour for @OncoAlert to Team up w/ @myESMO to examine the impact of #COVID19
Did you know: % of responde… twitter.com/i/web/status/1…
Did you know: % of responde… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
@ESOncology-ESMO 5th International Consensus Recommendations for adv #breastcancer: updates on managemt of all su… twitter.com/i/web/status/1…
8.
9.
10.
11.
Gil Morgan
@weoncologists
Just Outat @bmj_latest
Study suggests for most early #BreastCancer Single dose targeted intra-operative… twitter.com/i/web/status/1…
Study suggests for most early #BreastCancer Single dose targeted intra-operative… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
What the @OncoAlert network tries to do is to form an unofficial way of partnering and being there for our patient… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
It didn’t take long Shortly after @US_FDA approved the used Convalescent serum therapy (the use plasmafrom… twitter.com/i/web/status/1…
Gil Morgan
@weoncologists
Just Out @US_FDA approves CINtec PLUS Cytologyas the first biomarker-based triage test for women w/… twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
